A patient with asthma is initiated on a long-acting beta-agonist (LABA) as monotherapy. What is the primary safety concern?
-
A
Increased risk of paradoxical bronchospasm
-
B
Increased asthma-related mortality without concomitant ICS
-
C
Risk of cardiac arrhythmia at therapeutic doses
-
D
Development of tolerance within one week